Chronic bacterial inflammation of the gum: the main risk factor for posttransplant gingival hyperplasia?
Wirnsberger, G.H.; Pfragner, R.; Holzer, H.
Clinical Nephrology 51(1): 63-64
1999
ISSN/ISBN: 0301-0430 PMID: 9988152 Document Number: 498832
Document emailed within 1 workday
Related Documents
Kvantaliani, T.G.; Pargalava, N.S.; Tsiklauri, P.A.; Abzianidze, T.G. 2006: Chronic bacterial-and-viral vasculitis as a possible risk factor of disordered stability of the coronary atherosclerosis course Angiologiia i Sosudistaia Khirurgiia 12(3): 35-39Edwards, C.M.; Morgan, J.D.; Tilsed, J.V.; Donnelly, P.K. 1992: Impaired acute phase response: a risk factor for life-threatening posttransplant pancreatitis? Transplantation Proceedings 24(6): 2769
Li, Y.; Liu, S.; Wang, L.; Zhou, M. 2015: Burden of disease attributable to main behavioral risk factor of chronic disease inactivity in China, 1990 and 2010 Zhonghua Yu Fang Yi Xue Za Zhi 49(4): 303-308
Facchinetti, F.; Marozio, L.; Grandone, E.; Pizzi, C.; Volpe, A.; Benedetto, C. 2003: Thrombophilic mutations are a main risk factor for placental abruption Haematologica 88(7): 785-788
Mühlemann, H.R. 1977: Gingival inflammation Dental Cadmos 45(10): 18-28
Infante Cossío, P.; Torelló Iserte, J.; Espín Gálvez, F.; García-Perla, A.; Rodríguez-Armijo Sánchez, L.; Castillo Ferrando, J.R. 1997: Gingival hyperplasia associated with amlodipine Anales de Medicina Interna 14(2): 83-85
Royo, M.; Arto, A. 1992: Calcium antagonists and gingival hyperplasia Atencion Primaria 9(9): 517
Margolin, R.E.; Glazer, H.S.; Lesh, M.F. 1994: Drug-induced gingival hyperplasia General Dentistry 42(4): 344-345
González Romero, E.A.; López Sánchez, A.F.; Granados Menéndez, M.I.; Hernández Vallejo, G. 1995: Drug-induced gingival hyperplasia Atencion Primaria 16(6): 367-370; 372-373
Marcos Sánchez, F.; Arranz Nieto, M.J.; Celdrán Gil, J.; Durán Pérez Navarro, A. 1990: Gingival hyperplasia induced by nifedipine Anales de Medicina Interna 7(4): 215-216
Raman, P.G.; Mishra, V.N.; Singh, D. 1988: Nifedipine induced gingival hyperplasia Journal of the Association of Physicians of India 36(3): 231-233
Burkes, E.J.; Jacoway, J.R.; Stevens, D.T.; Braddock, M.E. 1992: Nifedipine-induced gingival hyperplasia Journal of the Tennessee Dental Association 72(2): 35-37
Puolijoki, H.; Siitonen, L.; Saha, H.; Suojanen, I. 1988: Nifedipine-induced gingival hyperplasia Duodecim; Laaketieteellinen Aikakauskirja 104(14): 1063-1066
Bokor-Bratić, M.; Vucković, N.; Selaković, S. 1998: Gingival hyperplasia during treatment with nifedipine Medicinski Pregled 51(9-10): 445-448
Gertenrich, R.L.; Brown, C.A. 1974: Treatment of Dilantin gingival hyperplasia with Proxigel American Journal of Mental Deficiency 78(4): 502-504
García Bernal, G.; Collado, A.; Cerón, A. 1991: Gingival hyperplasia as an adverse reaction to nifedipine Atencion Primaria 8(3): 265
Doria, G.; Cangemi, F.; Gulizia, M.; Lo Giudice, P.; Circo, A. 1990: 3 cases of gingival hyperplasia during nifedipine therapy Minerva Cardioangiologica 38(3): 97-100
Munthe-Kaas, A.; Storhaug, K. 1978: Tooth health, drugs, and gingival hyperplasia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 98(3): 161-162
Cooper, C.L.; Loewen, R.; Shore, T. 2000: Gingival hyperplasia complicating acute myelomonocytic leukemia Journal 66(2): 78-79
Li, Z.H. 1983: Congenital Hypertrichosis universalis associated with gingival hyperplasia and macromastia Zhonghua Yi Xue Za Zhi 63(6): 368-372